Skip to main content
SpringerLink
Log in
Book cover

Medizinökonomie pp 143–168Cite as

Pharma-Management

  • Chapter

  • 5118 Accesses

Part of the book series: FOM-Edition / FOM Hochschule für Oekonomie & Management ((FOMEDITION))

Zusammenfassung

Nach der Lektüre dieses Kapitels sollten Sie:

  • die Bedeutung eines Pharma-Unternehmens in der Wertschöpfungskette eines Medikaments verstehen.

  • die Wertschöpfungskette innerhalb des Pharma-Unternehmens verstehen

  • die Funktionen innerhalb eines Pharmaunternehmens und deren Optimierung kennen:

    1. a.

      Forschung & Entwicklung

    2. b.

      Produktion

    3. c.

      Sales & Marketing

    4. d.

      Regulatory Affairs

    5. e.

      Weitere Funktionen

  • die Komplexität des Managements eines Pharmaunternehmens verstehen.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Buchholz, S.: Future manufacturing approaches in the chemical and pharmaceutical industry. Chemical Engineering and Processing, 49, 2010, S. 993–995.

    Article  Google Scholar 

  2. Bhattacharya, C.B./Korschun, D.: Stakeholder Marketing: Beyond the Four Ps and the Customer. Journal of Public Policy & Marketing, 27, 2008, S. 113–16.

    Article  Google Scholar 

  3. Devlin, E./Hastings, G./ Smith, A./ McDermott, L./Noble, G.: Pharmaceutical marketing: a question of regulation. Journal of Public Affairs, 7.2, 2007, S. 135–147.

    Article  Google Scholar 

  4. DiMasi, J.A./Hansen, R.W./Grabowski, H.G.: The price of innovation: new estimates of drug development costs. Journal of Health Economics, 22.2, 2003, S. 151–185.

    Article  Google Scholar 

  5. Fischer, M./Albers, S.: Patient-or Physician-Oriented Marketing: What Drives Primary Demand for Prescription Drugs?Journal of Marketing Research, 47.1, 2010, S. 103–121.

    Article  Google Scholar 

  6. Jambulingam, T./Sharma, R.: Estimating the value of internet marketing in the US pharmaceutical industry. Journal of Medical Marketing, 2010, 10.4, S. 332–343.

    Article  Google Scholar 

  7. Kvesic, Dennis Z: Product Lifecycle Management: Marketing Strategies for the Pharmaceutical Industry. Journal of Medical Marketing, 8.4, 2008, S. 293–301.

    Article  Google Scholar 

  8. McGrath, S.: Market access. An essential investment before drug launch. Journal of Commercial Biotechnology, 16.3, 2010, S. 201–205.

    Google Scholar 

  9. Porter, M.E.: Competitive advantage. Free Press New York, 1985.

    Google Scholar 

  10. Jaume, P.J.: Impact of European Pharmaceutical Price Regulation on Generic Price Competition: A Review. PharmacoEconomics, 28.8, 2010, S. 649–663.

    Article  Google Scholar 

  11. www.cbo.gov/doc.cfm?index=7615. Abgerufen zuletzt am 15. April 2011.

Download references

Authors
  1. Rüdiger Buchkremer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ulrich Thibaut
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lohmar, Deutschland

    Christian Thielscher

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Gabler Verlag | Springer Fachmedien Wiesbaden GmbH

About this chapter

Cite this chapter

Buchkremer, R., Thibaut, U. (2012). Pharma-Management. In: Thielscher, C. (eds) Medizinökonomie. FOM-Edition / FOM Hochschule für Oekonomie & Management. Gabler Verlag. https://doi.org/10.1007/978-3-8349-7088-6_5

Download citation

Publish with us

Policies and ethics

Search

Navigation